Cargando…
miR-30a attenuates cardiac fibrosis in rats with myocardial infarction by inhibiting CTGF
The mechanism of miR-30a in myocardial fibrosis in rats with myocardial infarction (MI) was investigated. rAAV9-miR-30a was constructed and transfected to heart via injecting into the left ventricular cavity of MI rats. The sham operation group, control group, miR-30a group and miR-30a-NC group were...
Autores principales: | Chen, Liwen, Ji, Qian, Zhu, Hao, Ren, Yizhi, Fan, Zhongguo, Tian, Nailiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5962866/ https://www.ncbi.nlm.nih.gov/pubmed/29849775 http://dx.doi.org/10.3892/etm.2018.5952 |
Ejemplares similares
-
Comparison of the effect of rosuvastatin versus rosuvastatin/ezetimibe on markers of inflammation in patients with acute myocardial infarction
por: Ren, Yizhi, et al.
Publicado: (2017) -
MiR-375 attenuates injury of cerebral ischemia/reperfusion via targetting Ctgf
por: Ou, Jianying, et al.
Publicado: (2017) -
Myocardial Connective Tissue Growth Factor (CCN2/CTGF) Attenuates Left Ventricular Remodeling after Myocardial Infarction
por: Gravning, Jørgen, et al.
Publicado: (2012) -
Exosome-encapsulated miR-26a attenuates aldosterone-induced tubulointerstitial fibrosis by inhibiting the CTGF/SMAD3 signaling pathway
por: Zheng, Hui, et al.
Publicado: (2022) -
CTGF in kidney fibrosis and glomerulonephritis
por: Toda, Naohiro, et al.
Publicado: (2018)